Stevens-Johnson/toxic epidermal necrolysis overlap syndrome following lenalidomide treatment for multiple myeloma relapse after allogeneic transplantation

Ann Hematol. 2012 Feb;91(2):287-9. doi: 10.1007/s00277-011-1235-y. Epub 2011 Apr 15.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / adverse effects*
  • Humans
  • Lenalidomide
  • Middle Aged
  • Multiple Myeloma / complications
  • Multiple Myeloma / prevention & control*
  • Multiple Myeloma / therapy*
  • Recurrence
  • Stevens-Johnson Syndrome / chemically induced*
  • Stevens-Johnson Syndrome / etiology*
  • Stevens-Johnson Syndrome / pathology
  • Thalidomide / adverse effects
  • Thalidomide / analogs & derivatives*
  • Transplantation, Homologous*

Substances

  • Antineoplastic Agents
  • Thalidomide
  • Lenalidomide